-
A new era in cancer care: Lavine Bekenstein Cancer Hospital at Dana-Farber
The Lavine Bekenstein Cancer Hospital at Dana-Farber will be the only independent cancer hospital in the region.
-
More than a building name
The historic joint commitment from Anita and Josh Bekenstein and the Jeannie and Jonathan Lavine Family, the largest single gift in Dana-Farber’s history, will help advance a new hospital designed entirely around the needs of cancer patients and their families.
-
Yawkey Foundation bridging generations of cancer research and care
The Jean and Tom Yawkey Bridge will stand as a special testament to a partnership that has helped carry Dana-Farber from one era of cancer care to the next.
-
From education to excellence: Lubin Family gift supports future of cancer care
Richard Lubin has been deeply involved with Dana-Farber Cancer Institute for more than three decades.
-
Honoring a foundation of leadership
The specialty floor that will bear the names of past presidents, David G. Nathan, MD, Edward J. Benz Jr., MD, and Laurie H. Glimcher, MD, PhD, in the Lavine Bekenstein Cancer Hospital will one day be a place of highly specialized cancer care.
-
A legacy of giving that makes compassionate care possible
The Rosenberg family has long supported cancer patient treatment and care across Boston, a commitment rooted in the values of Leon V. and Marilyn L. Rosenberg and carried forward through generations.
-
Building a visionary healing environment
Since joining the Dana-Farber Cancer Institute Board of Trustees in 2014, Phill Gross has supported Dana-Farber's rapid growth and progress toward a world free from the burden of cancer.
-
Building the future, one ride at a time
Andrew “AJ” Janower and Cindy Janower recently committed $2.5 million through the Pan-Mass Challenge (PMC) to support construction of the facility.
-
The Mark Foundation for Cancer Research targets hard-to-treat diseases
The Mark Foundation for Cancer Research has recently awarded $4.1 million in grants to Dana-Farber Cancer Institute scientists targeting pancreatic cancer, acute myeloid leukemia, and pediatric brain tumors.
-
Blood Cancer United grants foster research equity, target deadly blood cancers
Five Dana-Farber Cancer Institute investigators are the recipients of $4.2 million in grants from Blood Cancer United to support their innovative work in blood cancer research.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.